Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer - but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.from EUROPA - Syndicated Research News Feed https://ift.tt/2u0dq4N
via IFTTT
No comments:
Post a Comment